EUVIMEDEUVIMED entdecken
Crossref

Combined Therapy for Chronic HCV With Interferon-α Plus Ribavirin Improved Insulin Resistance but did not Affect the Adiponectin Levels

Shih-Ting Tseng, Wen-Ta Chiu, Hui-Er Wang, Kuan-Chou Chen, Robert Y. Peng

Journal of Experimental & Clinical Medicine · 2011

DOI: 10.1016/j.jecm.2010.12.004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Experimental & Clinical Medicine, 2011. Verfasst von Shih-Ting Tseng und 4 weiteren Autor:innen. Die Arbeit nennt 24 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Tseng, S., Chiu, W., Wang, H., Chen, K., & Peng, R. Y. (2011). Combined Therapy for Chronic HCV With Interferon-α Plus Ribavirin Improved Insulin Resistance but did not Affect the Adiponectin Levels. Journal of Experimental & Clinical Medicine. https://doi.org/10.1016/j.jecm.2010.12.004

Vancouver

Tseng S, Chiu W, Wang H, Chen K, Peng RY. Combined Therapy for Chronic HCV With Interferon-α Plus Ribavirin Improved Insulin Resistance but did not Affect the Adiponectin Levels. Journal of Experimental & Clinical Medicine. 2011. doi:10.1016/j.jecm.2010.12.004

BibTeX
@article{Tseng2011,
  author = {Tseng, Shih-Ting and Chiu, Wen-Ta and Wang, Hui-Er and Chen, Kuan-Chou and Peng, Robert Y.},
  title = {Combined Therapy for Chronic HCV With Interferon-α Plus Ribavirin Improved Insulin Resistance but did not Affect the Adiponectin Levels},
  journal = {Journal of Experimental & Clinical Medicine},
  year = {2011},
  doi = {10.1016/j.jecm.2010.12.004}
}
Kostenlos starten →